1-4 of 4
Yen-Hong Kuo, PHD
Close
Sort by
Journal Articles

One Size May Not Fit All for TKI Dosing in Chronic Phase CML—Deep Molecular Responses Despite Dose Reduction

James K McCloskey, MD, Genique Stanislaus, ANP, Yen-Hong Kuo, PhD, Jamie Koprivnikar, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5448.
https://doi.org/10.1182/blood-2018-99-119971
Published: 2018
Journal Articles

Blinatumumab Induces Responses in Extramedulary B-Cell Acute Lymphoid Leukemia (B-ALL) and Lymphoid Blast Crisis Chronic Myelogenous Leukemia (CML), and Rarely Results in CD19 Negative Relapse

Jamie Koprivnikar, MD, Danielle Marcotulli, APN, Elizabeth Jones, RN, Grace Perry, APN, Yen-Hong Kuo, PhD, Joelle Gagnon, NP, Maritess Aviador, RN, Genique Stanislaus, ANP, James McCloskey, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2703.
https://doi.org/10.1182/blood-2018-99-120172
Published: 2018
Journal Articles

Real-World Outcomes with Panobinostat in Patients with Relapsed/Refractory Multiple Myeloma

Noa Biran, MD, David H. Vesole, MD PhD, Shijia Zhang, MD PhD, Joshua R. Richter, MD, Yen-Hong Kuo, PhD, Linda Schmidt, RN BSN MSN OCN CNL, Laura McBride, RN, BSN, OCN, CCRP, Palka Anand, BSN, Kristin Ivanovski, RN, Amy Pierre, RN, MSN, APN, Susan Kumka, RN, MSN, APN, Carmela Cuccurullo, RN, MSN, APN, David S. Siegel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5685.
https://doi.org/10.1182/blood.V128.22.5685.5685
Published: 2016
Journal Articles

PET Scan Negativity Post Treatment In DLBCL May Not Indicate A Cure

David Atherton, BS, Mila Lachica, BA, CCRP, Yen-Hong Kuo, PHD, Arthur A. Topilow, MD, FACP
Journal: Blood
Blood (2013) 122 (21): 5053.
https://doi.org/10.1182/blood.V122.21.5053.5053
Published: 2013